激素替代疗法（HRT）的乳腺癌风险取决于治疗类型和持续时间。
Risk of breast cancer with HRT depends on therapy type and duration.
机构信息
NIHR Centre for Engagement and Dissemination, Twickenham, UK.
University of Nottingham, UK.
出版信息
BMJ. 2022 Mar 8;376:o485. doi: 10.1136/bmj.o485.
DOI:10.1136/bmj.o485
PMID:35260385
Abstract
The studyVinogradova Y, Coupland C, Hippisley-Cox J. Use of hormone replacement therapy and risk of breast cancer: nested case-control studies using the QResearch and CPRD databases. 2020;371:m3873. To read the full NIHR Alert, go to: https://evidence.nihr.ac.uk/alert/risk-of-breast-cancer-with-hrt-depends-therapy-type-and-duration/.
摘要
文戈罗娃 Y、库普兰 C、希皮斯利-考克斯 J 进行的研究。激素替代疗法的使用与乳腺癌风险：使用 QResearch 和 CPRD 数据库的嵌套病例对照研究。2020；371：m3873。要阅读完整的 NIHR 警报，请访问：https://evidence.nihr.ac.uk/alert/risk-of-breast-cancer-with-hrt-depends-therapy-type-and-duration/。
Zotero 插件